Last edition
News about "Rajeev Kumar Jain"
Supriya Lifescience appoints Rajeev Kumar Jain as CEO
He has over 35+ years of rich functional experience in the manufacturing domain of bulk drugs, intermediate and API
Rajeev Kumar Jain | 03/10/2022 | By Sudeep Soparkar | 551
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members